Christopher Pimentel Email & Phone Number

Franklin Township, Nj, Us

Raritan, New Jersey, United States

• Lead all financial reporting and analytics for Global R&D Ops/Functions actual and forecasting process related to E2E consolidations of $4.5B of Innovative Medicine R&D investment. • Present business results of Global R&D Ops/Functions to Innovative Medicine R&D finance leadership team (R&D CFO, R&D VP, and Functions Sr. Director) to provide strategic and long-term financial planning insights.• Run, approve, and escalate scenarios using planning tools to provide E2E portfolio insights that help aid in strategic portfolio prioritization decisions that ensure pipeline strength and efficient supply chain planning. • Proactively reshape and design reporting capabilities through the implementation of best-in-class FP&A practices by creating PowerBi dashboards (Headcount, PnL Reporting, etc.) to enhance reporting metrics and provide readily available data for forecasting and real time decision making. • Manage Clinical Out of Pocket (~$0.5B annually) through close partnership with CRO’s, Procurement, Partnership Accountability, CFS, and other key R&D partners to help optimize management of strategic vendors and improve planning for clinical trials to drive alignment and harmonization across R&D programs. • Proactively collaborate with Procurement, Strategic Partnerships, and across R&D Finance to manage the relationship with our Flex vendors for ~4,000 Headcount/$0.5B of annual spend and simplify data collection through the creation of an automated Alteryx model.• Collaborate with 50+ countries through effective communication to ensure that ~$0.5B of R&D out of pocket and FTE related expenses from non-R&D entities are allocated and captured on the R&D books (actual and planning). • Champion change to simplify, standardize, and automate the R&D Global Functions consolidations for actual and planning cycles. • Provide leadership for the performance and development of a global team of eight to drive value creation and top performing talent.

Titusville, New Jersey, United States

• Provided base business financial leadership for Innovative Medicine Supply Chain North America Gross-to-Net Inventory related to Inventory Reserves, SLOB, Full Absorption and Revaluation by partnering closely with Tax, Capacity Planning, Deliver, and R&D. • Collaborated with capacity planning to focus on long-term forecasting accuracy and drive short-term actions to maximize sales and profitability for North America• Developed strong relationships with business partners to develop automation and continuous process enhancements that expedited quarter close, IBP, and Supply Chain planning activities related to gross inventory and inventory reserves for North America. • Championed change to ensure adoption of a strategic business continuity plan across our North America distribution centers by collaborating with Tax, Deliver and Capacity Planning, which maximized JNJ’s annual Tax savings, profitability, and availability of product.• Key leader in the development and setup of our COVID-19 vaccine supply chain financials, which supplied ~1 million doses worldwide and accounted for ~$5 billion in sales.• Provided financial support and analytics for one of our supply chain site closures and implementation of new product flows to maintain a seamless transition and continuation of our product manufacturing. • Successfully provided leadership for the performance and development of a team of nine to drive value creation. • Partnered closely with Global Supply Chain to train and develop talent on best practices for inventory accounting relating to actuals and forecasting. • Led the development and presentation of Innovative Medicine Supply Chain Finance Town Halls for Senior Leadership to ensure a normal cadence of E2E financial reviews relating to actuals, short-term planning and long-term planning for forecast cycles.

Raritan, New Jersey, United States

• Provided base business financial support for Innovative Medicine Supply Chain Affiliate Gross Profit elimination and alignment for North America, Puerto Rico, and Vacaville. • Proactively collaborated cross-functionally to initiate and implement continuous process improvements, which expedited close activities related to affiliate royalties and North America affiliate gross profit. • Collaborated with multiple affiliate sites and Tax to calculate intercompany prices contributing to JNJ annual Tax savings of roughly $4B.• Key leader to champion change for the develop and implementation of the affiliate gross profit model for our Vacaville site transition to the Supply Chain CoE. • Provided Financial support for new product master data setup and business continuation accounting to ensure E2E financial accuracy and profitability. • Successfully led an intercompany workstream to automate Puerto Rico billings and developed metrics to provide enhanced compliance, on-going accountability, and risk mitigation. • Partnered closely with Tax through effective communication to influence and align on Transfer Price strategy models to complete the annual standard setting process and calculate inbound prices of 1,000+ materials.

Somerville, New Jersey, United States

• Provided base business financial support for the Wound Closure Portfolio to help influence management decision making.• Forecasted product code level Sales, Cost of Goods Sold, Quantity and Gross Profit for multiple planning cycles.• Managed various reporting responsibilities for Wound Closure Alternate Channel Strategies. • Created financial dashboards to inform business partners of risks/opportunities versus current business targets.• Initiated monthly Wound Closure performance presentations with Marketing senior executives to provide an update on key performance metrics.

Newark, New Jersey, United States

• Prepared the monthly and quarterly impairment review of securities on a GAAP and Statutory basis.• Conducted quarterly presentations with asset managers to evaluate impairment recommendations and provide guidance around the impairment policy.• Prepared the Investment Footnote, General Account MD&A, and Realized Gains/(Losses) MD&A for the Company’s 10Q/10K filings.

Compile monthly metrics data into tracker/scorecard to help monitor intercompany corporate monthly transactions.Book journal entries for all intercompany corporate purchase orders on a monthly basis to ensure no out of balances.Manage and maintain intercompany mailbox through successful communication with affiliates over intercompany processes and functions.Develop purchase order tracker to be able to communicate information more efficiently with affiliates.Create a user friendly scorecard to efficiently enhance the monthly metrics meeting.Help in the analyzing our open items through providing a breakdown to the intercompany team.Conduct WINGS training at Corporate Headquarters to help our business partners better understand the WINGS process.